tiprankstipranks
Trending News
More News >
HealthCo Healthcare & Wellness REIT (AU:HCW)
ASX:HCW
Australian Market
Advertisement

HealthCo Healthcare & Wellness REIT (HCW) AI Stock Analysis

Compare
24 Followers

Top Page

AU:HCW

HealthCo Healthcare & Wellness REIT

(Sydney:HCW)

Rating:51Neutral
Price Target:
AU$1.00
▲(35.14% Upside)
The overall stock score of 51 reflects significant challenges in financial performance, with declining revenue and profitability being the most impactful factors. Technical analysis provides a mixed view, with some short-term support but overall weak momentum. Valuation concerns are evident due to negative earnings, though the high dividend yield offers some compensation for risk.

HealthCo Healthcare & Wellness REIT (HCW) vs. iShares MSCI Australia ETF (EWA)

HealthCo Healthcare & Wellness REIT Business Overview & Revenue Model

Company DescriptionHealthCo Healthcare & Wellness REIT (HCW) is a real estate investment trust that specializes in owning, managing, and developing properties in the healthcare and wellness sectors. The company focuses on a diverse portfolio of assets including hospitals, outpatient facilities, senior living communities, and wellness centers. HCW aims to enhance the quality of healthcare delivery by providing state-of-the-art facilities and partnering with leading healthcare operators.
How the Company Makes MoneyHealthCo Healthcare & Wellness REIT generates revenue primarily through leasing its properties to healthcare operators and wellness providers. The company enters into long-term lease agreements with tenants, ensuring a stable and predictable income stream. Additionally, HCW may engage in strategic partnerships and joint ventures to expand its portfolio and enhance its service offerings. The company also benefits from property appreciation and may pursue capital recycling strategies by selling underperforming or non-core assets to reinvest in higher-yield opportunities.

HealthCo Healthcare & Wellness REIT Financial Statement Overview

Summary
HealthCo Healthcare & Wellness REIT faces challenges with declining revenue and profitability, impacting its financial performance. The balance sheet shows moderate stability, but cash flow management requires attention. The company needs to address operational inefficiencies and improve cash conversion to enhance financial health.
Income Statement
45
Neutral
The income statement shows a concerning trend with declining revenue and profitability. The company experienced a significant revenue decline of 13.26% in the latest year, and the net profit margin turned negative, indicating losses. The gross profit margin remains relatively strong, but the negative EBIT and EBITDA margins highlight operational challenges.
Balance Sheet
60
Neutral
The balance sheet reflects moderate financial stability with a manageable debt-to-equity ratio of 0.57. However, the return on equity is negative, indicating inefficiencies in generating returns for shareholders. The equity ratio is healthy, suggesting a solid asset base relative to liabilities.
Cash Flow
50
Neutral
Cash flow analysis reveals mixed results. While there is positive free cash flow growth, the operating cash flow to net income ratio is low, suggesting potential issues in converting earnings into cash. The free cash flow to net income ratio is stable, but overall cash flow management needs improvement.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue53.00M53.00M64.00M40.20M24.46M
Gross Profit36.10M36.10M47.00M24.30M16.31M
EBITDA36.10M-64.10M49.40M33.80M52.93M
Net Income-88.80M-88.80M6.90M20.20M49.61M
Balance Sheet
Total Assets1.27B1.27B1.44B1.72B693.60M
Cash, Cash Equivalents and Short-Term Investments40.50M40.50M19.90M7.60M2.69M
Total Debt448.30M448.30M481.10M703.70M22.29M
Total Liabilities478.30M478.30M521.50M766.20M39.51M
Stockholders Equity788.00M788.00M912.60M951.20M654.09M
Cash Flow
Free Cash Flow23.30M18.30M6.40M888.90M-473.92M
Operating Cash Flow23.30M18.30M6.40M11.10M19.96M
Investing Cash Flow78.90M83.90M41.50M-961.90M-522.47M
Financing Cash Flow-81.60M-81.60M-35.60M944.10M501.58M

HealthCo Healthcare & Wellness REIT Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.74
Price Trends
50DMA
0.77
Negative
100DMA
0.80
Negative
200DMA
0.89
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
37.60
Neutral
STOCH
13.31
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HCW, the sentiment is Negative. The current price of 0.74 is below the 20-day moving average (MA) of 0.79, below the 50-day MA of 0.77, and below the 200-day MA of 0.89, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 37.60 is Neutral, neither overbought nor oversold. The STOCH value of 13.31 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:HCW.

HealthCo Healthcare & Wellness REIT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
AU$673.93M12.6324.81%3.97%11.19%34.96%
73
Outperform
AU$422.91M10.787.93%6.73%-3.97%1057.09%
55
Neutral
AU$105.14M-2.01%3.08%-5.21%-14350.00%
53
Neutral
AU$743.68M-1.91%8.08%-4.50%88.28%
53
Neutral
AU$69.04M-23.55%12.35%-70.24%42.03%
53
Neutral
$1.21B2.92-5.63%5.83%-2.99%-79.62%
51
Neutral
AU$407.13M78.69-10.44%11.14%-16.67%-1419.67%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HCW
HealthCo Healthcare & Wellness REIT
0.74
-0.45
-37.82%
AU:COF
Centuria Office REIT
1.24
0.13
11.71%
AU:DXC
Dexus Convenience Retail REIT
3.07
0.37
13.70%
AU:AOF
Australian Unity Office Fund
0.42
-0.06
-12.50%
AU:WOT
WOTSO Property
0.65
-0.07
-9.72%
AU:SRV
Servcorp Limited
6.80
2.29
50.78%

HealthCo Healthcare & Wellness REIT Corporate Events

HealthCo Healthcare & Wellness REIT Announces 2025 Financial Results Release Dates
Jul 16, 2025

HealthCo Healthcare & Wellness REIT, part of HMC Capital, has announced the schedule for releasing its full-year financial results for the year ended June 30, 2025. The results will be disclosed over several days in August 2025, with associated conference calls and webcasts available for stakeholders. This announcement is crucial for investors and stakeholders as it provides insights into the company’s financial performance and strategic positioning in the healthcare and wellness real estate sector.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HealthCo Healthcare & Wellness REIT Reports Valuation Decrease and Suspends Quarterly Distribution
Jun 24, 2025

HealthCo Healthcare & Wellness REIT announced a preliminary unaudited portfolio valuation of $1.5 billion, reflecting a 4.3% gross decrease from the previous valuation due to cap rate expansion. The company will not declare a quarterly distribution for the period from April to June 2025 to preserve balance sheet liquidity. Alternative hospital operators are conducting due diligence on all 11 private hospitals owned by HCW and the Unlisted Healthcare Fund. This decision and the valuation adjustment indicate a strategic focus on maintaining financial stability amid market fluctuations.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HealthCo REIT Secures Rent Deferral to Sustain Hospital Operations
May 29, 2025

HealthCo Healthcare & Wellness REIT and the Unlisted Healthcare Fund have agreed to a short-term partial rent deferral with Healthscope and its Receivers to ensure the continuity of services at 11 private hospitals. This agreement includes immediate payment of outstanding rents for March and April 2025, and 85% of rent for May 2025, with the remaining 15% deferred until September 2025. The landlords are also in discussions about the Healthscope sale process and have received interest from other hospital operators to re-tenant the facilities, indicating a strategic move to maintain operations and explore new partnerships.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HealthCo REIT Maintains Stability Amid Healthscope Receivership
May 27, 2025

HealthCo Healthcare & Wellness REIT (ASX:HCW) and the Unlisted Healthcare Fund (UHF) have announced that two entities within the Healthscope group have entered into receivership and administration. However, the entities that HCW and UHF contract with remain operational and unaffected by the receivership. The existing legal rights of HCW and UHF, including cross default and termination rights, remain intact, although termination rights are not currently enforceable. This situation underscores the resilience of HCW’s operations and its strategic positioning in the healthcare property market, ensuring stakeholders that their investments remain secure despite the challenges faced by Healthscope.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HMC Capital Showcases Strategic Strengths at Macquarie Conference
May 5, 2025

HMC Capital presented at the 2025 Macquarie Australia Conference, highlighting its strategic focus and operational strengths. The presentation underscores HMC Capital’s ability to manage substantial funds and execute complex deals, reinforcing its position in the alternative asset management industry and its commitment to delivering strong returns for its investors.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 25, 2025